Oncolys BioPharma Inc.
Loading...
Key Metrics
Market Cap
N/A
P/E Ratio
N/A
P/B Ratio
N/A
Revenue
31.4M
Net Income
-1.7B
Gross Margin
N/A
Op. Margin
-53.6%
Net Margin
-53.7%
ROE
-61.2%
ROA
-52.7%
D/E
0.16
Dividend Yield
N/A
EPS
-77.17
Current Ratio
12.28
Price History
Company Info
| Industry | PHARMACEUTICAL |
| Market Segment | Growth |
| Accounting | Japan GAAP |
| Currency | JPY |
| Fiscal Year | 2024 |
Peers
9.1T
P/E: 81.3
Astellas Pharma Inc.
4503
4.3T
P/E: 34.2
Shionogi & Co.,Ltd.
4507
2.9T
P/E: 16.8
Kyowa Kirin Co.,Ltd.
4151
1.2T
P/E: 18.3
736.8B
P/E: 4.8
542.5B
P/E: 18.2
337.9B
P/E: 10.6
159.8B
P/E: 294.1
Financial Statements
Loading financials...
Open Advanced Charts
Full charting with technical indicators, candlestick, and more.
| Ticker | 4588 |
| Exchange | TSE |
| Sector | Pharmaceutical |
| Industry | PHARMACEUTICAL |